These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31479731)

  • 1. ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept study.
    Oddone N; Pederzoli F; Duskey JT; De Benedictis CA; Grabrucker AM; Forni F; Angela Vandelli M; Ruozi B; Tosi G
    Int J Pharm; 2019 Oct; 570():118655. PubMed ID: 31479731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
    Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
    Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
    Yin W; Ke W; Chen W; Xi L; Zhou Q; Mukerabigwi JF; Ge Z
    Biomaterials; 2019 Mar; 195():63-74. PubMed ID: 30612064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, and
    Oddone N; Boury F; Garcion E; Grabrucker AM; Martinez MC; Da Ros F; Janaszewska A; Forni F; Vandelli MA; Tosi G; Ruozi B; Duskey JT
    Front Pharmacol; 2020; 11():574. PubMed ID: 32425795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
    Shen C; Zhao L; Du X; Tian J; Yuan Y; Jia M; He Y; Zeng R; Qiao R; Li C
    Mol Pharm; 2021 Mar; 18(3):1419-1430. PubMed ID: 33522827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoparticles responsive to intracellular ROS for anticancer drug delivery.
    Xu L; Zhao M; Gao W; Yang Y; Zhang J; Pu Y; He B
    Colloids Surf B Biointerfaces; 2019 Sep; 181():252-260. PubMed ID: 31153020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-demand PEGylation and dePEGylation of PLA-based nanocarriers
    Zhu Y; Chen C; Cao Z; Shen S; Li L; Li D; Wang J; Yang X
    Theranostics; 2019; 9(26):8312-8320. PubMed ID: 31754398
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases.
    Wang P; Gong Q; Hu J; Li X; Zhang X
    J Med Chem; 2021 Jan; 64(1):298-325. PubMed ID: 33356214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ROS-responsive polymeric micelle with a π-conjugated thioketal moiety for enhanced drug loading and efficient drug delivery.
    Sun C; Liang Y; Hao N; Xu L; Cheng F; Su T; Cao J; Gao W; Pu Y; He B
    Org Biomol Chem; 2017 Nov; 15(43):9176-9185. PubMed ID: 29072771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery.
    Li M; Gao M; Fu Y; Chen C; Meng X; Fan A; Kong D; Wang Z; Zhao Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():11-18. PubMed ID: 26731193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpene-Based Prodrug for Self-Boosted Drug Release and Targeted Oral Squamous Cell Carcinoma Chemotherapy.
    Zhong J; He G; Ma X; Ye J; Tao ZY; Li Z; Zhang F; Feng P; Wang Y; Lan X; Su YX
    ACS Appl Mater Interfaces; 2024 Aug; 16(32):41960-41972. PubMed ID: 39082953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
    Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
    Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria.
    Reshetnikov V; Daum S; Janko C; Karawacka W; Tietze R; Alexiou C; Paryzhak S; Dumych T; Bilyy R; Tripal P; Schmid B; Palmisano R; Mokhir A
    Angew Chem Int Ed Engl; 2018 Sep; 57(37):11943-11946. PubMed ID: 30035345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy.
    Pei P; Sun C; Tao W; Li J; Yang X; Wang J
    Biomaterials; 2019 Jan; 188():74-82. PubMed ID: 30336287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reactive oxygen species stimuli-responsive nanocarriers].
    Zhou W; Yang K; Zhao B; Zhang L; Zhang Y
    Se Pu; 2021 Feb; 39(2):118-124. PubMed ID: 34227343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
    Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
    J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIWV tetrapeptide and ROS-responsive prodrug conjugate for advanced glioblastoma therapy.
    Park YK; Jangili P; Zi S; Kang RH; Kim D; Kim JS
    Chem Commun (Camb); 2022 Sep; 58(78):10941-10944. PubMed ID: 36082694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
    Maslah H; Skarbek C; Pethe S; Labruère R
    Eur J Med Chem; 2020 Dec; 207():112670. PubMed ID: 32858470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.